Dayton, NJ, United States of America

Ping Lan


 

Average Co-Inventor Count = 14.1

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Dayton, NJ (US) (2012 - 2016)
  • Plainsboro, NJ (US) (2016 - 2021)

Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Ping Lan

Introduction

Ping Lan is a notable inventor based in Dayton, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable advancements in the development of compounds that address various health conditions.

Latest Patents

Among his latest patents, Ping Lan has developed substituted tetrahydroisoquinoline compounds that serve as GPR120 agonists. These compounds are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, NASH, inflammation-related disorders, and other related diseases and conditions. The compounds are particularly valuable as agonists of the G-protein coupled receptor GPR120. Additionally, he has created Factor XIIa inhibitors, which are compounds designed to treat or prevent thromboses, embolisms, hypercoagulability, or fibrotic changes. These compounds are selective Factor XIIa inhibitors and are included in pharmaceutical compositions for effective treatment.

Career Highlights

Throughout his career, Ping Lan has worked with prominent companies such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme Corp. His work in these organizations has contributed to the advancement of pharmaceutical research and development.

Collaborations

Ping Lan has collaborated with esteemed colleagues, including Zhongxiang Sun and Qun Dang, to further enhance his research and innovation in the pharmaceutical field.

Conclusion

Ping Lan's innovative work and numerous patents reflect his dedication to improving health outcomes through pharmaceutical advancements. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…